Putting the stress on senescence

Current Opinion in Cell Biology

Volumn 13, Issue 6, 2001, Pages 748-753

  Serrano, M ^a   Blasco, M A ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; TELOMERASE; TRANSCRIPTION FACTOR;

CARCINOGENESIS; CELL PROLIFERATION; DNA DAMAGE; HUMAN; ONCOGENE; ONCOGENE MYC; ONCOGENE RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE; STRESS; TELOMERE;

EID: 0035545802     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(00)00278-7     Document Type: Review

References (63)

1. How and why we age
2. The role of senescence and immortalization in carcinogenesis
3. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro
4. Telomeres and telomerase
5. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
6. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice
7. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
8. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
9. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
10. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans
11. Extension of life-span by introduction of telomerase into normal human cells
12. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
13. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
14. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life span human fibroblasts
15. Risky immortalization by telomerase
16. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
17. Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
18. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
19. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor-beta growth inhibition in p16INK4A(-) human mammary epithelial cells
20. Increased epidermal tumors and increased wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes
21. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts
22. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang
23. The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang
24. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2
25. INK4a
26. Tumor suppressors and oncogenes in cellular senescence
27. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase
28. Evidence for a telomere-independent 'clock' limiting RAS oncogene-driven proliferation of human thyroid epithelial cells
29. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation
30. p19ARF links the tumour suppressor p53 to Ras
31. Escape from premature senescence is not sufficient for oncogenic transformation by Ras
32. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization
33. Ablation of the retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions
34. ARF act in overlapping pathways in cellular immortalization
35. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
36. Senescence of human fibroblasts induced by oncogenic Raf
37. INK4a expression during cellular senescence
38. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a
39. Id-1 delays senescence but does not immortalize keratinocytes
40. INK4a expression
41. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation and tumorigenesis
42. JunD protects cells from p53-dependent senescence and apoptosis
43. ARF) and is amplified in a subset of human breast cancers
44. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
45. PML is induced by oncogenic ras and promotes premature senescence
46. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
47. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent
48. Histone deacetylases in replicative senescence: Evidence for a senescence-specific form of HDAC-2
49. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes
50. Cellular senescence as a tumor-protection mechanism: The essential role of counting
51. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species
52. Molecular mechanisms of the biological clock in cultured fibroblasts
53. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
54. Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells
55. Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia
56. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries
57. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
58. Ink4a confers susceptibility to metastatic melanoma in mice
59. Arf predisposes mice to tumourigenesis
60. Ink4a loss on senescence of murine bone marrow-derived pre B-cells and macrophages
61. ARF in replicative and induced senescence of human fibroblasts
62. Lack replicative senescence in cultured rat oligodendrocyte precursor cells
63. Lack of replicative senescence in normal rodent glia